Pharmaceutical Grade Gelatin Powder Market Size, Share, Growth, and Industry Analysis, By Type (Bone, Skin), By Application (Hard Capsule, Soft Capsule, Tablet, Plasma Substitute, Other) and Regional Forecast to 2033

PHARMACEUTICAL GRADE GELATIN POWDER MARKET REPORT OVERVIEW

The global Pharmaceutical Grade Gelatin Powder Market is poised for significant growth, starting at USD 0.9 billion in 2024, rising to USD 0.95 billion in 2025, and projected to reach USD 1.45 billion by 2033, with a CAGR of 5.4% from 2025 to 2033.

Pharmaceutical Grade Gelatin Powder Market serves as a vital ingredient in various medicinal formulations due to its high purity and quality standards. Extracted from collagen, it finds extensive use in pharmaceuticals for encapsulating drugs, manufacturing soft gel capsules, and stabilizing emulsions. With its excellent binding properties and biocompatibility, pharmaceutical grade gelatin powder ensures the effective delivery of medications while meeting stringent regulatory requirements. Its versatility, safety, and reliability make it indispensable in the pharmaceutical industry, contributing significantly to the development and production of various medicinal products.

COVID-19 Impact

Market Growth Restrained by Pandemic due to Economic Downturn

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The COVID-19 pandemic has exerted a negative impact on the Pharmaceutical Grade Gelatin Powder Market share. Supply chain disruptions, logistical challenges, and workforce limitations have hindered the production and distribution of pharmaceutical ingredients, including gelatin powder. Reduced manufacturing capacities, coupled with increased demand for healthcare products, have led to supply shortages and price fluctuations. Moreover, the economic downturn has prompted pharmaceutical companies to reevaluate their budgets and prioritize essential expenses, potentially affecting investments in new drug formulations that utilize gelatin powder. Despite these challenges, ongoing research and development efforts aim to mitigate the pandemic's effects and ensure a sustainable market recovery for pharmaceutical grade gelatin powder.

LATEST TRENDS

"Emphasis On Sustainable Products to Propel Market Growth"

Recent trends in the pharmaceutical grade gelatin powder market include a growing emphasis on sustainable sourcing and production methods to meet increasing consumer demand for environmentally friendly products. Additionally, advancements in technology have led to the development of novel gelatin formulations with improved properties and functionalities, expanding its applications in drug delivery systems and pharmaceutical formulations. Moreover, rising investments in research and development are driving innovation in gelatin-based medical devices and regenerative medicine applications. Furthermore, stringent regulatory standards and quality control measures continue to shape the market landscape, ensuring the safety and efficacy of pharmaceutical grade gelatin powder products.

PHARMACEUTICAL GRADE GELATIN POWDER MARKET SEGMENTATION

By Type

Based on type the market can be categorized bone, skin

• Bone: Gelatin, derived from animal bones, particularly bovine or porcine sources, is renowned for its strong gelling properties. This type of gelatin finds extensive use in pharmaceutical formulations such as capsules, tablets, and coatings. Its robust gelling ability ensures the structural integrity and controlled release of medications, making it a preferred choice for various drug delivery systems.
• Skin: Gelatin is obtained from the hides and skins of animals, primarily sourced from bovine and porcine origins. Skin gelatin is valued for its high purity and clarity, making it suitable for applications requiring transparency, such as clear capsules and oral solutions. Its clarity ensures an aesthetically pleasing appearance while maintaining the necessary functionality in pharmaceutical formulations.

By Application

Based on application the market can be categorized into hard capsule, soft capsule, tablet, plasma substitute, other.

• Hard capsules: Represent one of the primary applications of pharmaceutical grade gelatin powder. These capsules, typically made from two-piece shells, are filled with powdered or granulated medications. Gelatin serves as the encapsulating material, providing a stable and easily digestible shell for containing the active ingredients. Hard capsules offer precise dosage delivery and protection of medications from environmental factors.
• Soft capsules: These are also known as soft gels, are another significant application of pharmaceutical grade gelatin powder. These capsules are composed of a single-piece shell containing a liquid or semi-solid medication. Gelatin serves as the shell material, offering flexibility and easy swallowing for patients. Soft capsules enhance bioavailability and allow for the encapsulation of lipophilic compounds, making them suitable for a wide range of pharmaceutical formulations.
• Tablet: These are solid dosage forms composed of powdered or granulated medications compressed into a specific shape. Pharmaceutical grade gelatin powder may be utilized as a binder or coating agent in tablet formulations. Gelatin enhances the cohesion of tablet ingredients, facilitating tablet formation and improving stability.
• Plasma substitutes: They represent a specialized application of pharmaceutical grade gelatin powder in the medical field. Gelatin-based plasma substitutes are used to replace lost blood volume in cases of haemorrhage or surgery. These substitutes help maintain blood pressure and tissue perfusion, providing temporary support until the patient's own blood volume can be restored.
• Others: formulations encompass various pharmaceutical products where gelatin serves as a crucial ingredient. This may include suspensions, emulsions, gels, and topical formulations, among others. Gelatin contributes to the stability, texture, and consistency of these products, ensuring their effectiveness and quality.

DRIVING FACTORS

"Increased Demand for Soft gel Capsules Helps the Market Growth"

Soft gel capsules have gained popularity in the pharmaceutical industry due to their ease of swallowing, improved bioavailability, and precise dosage delivery. Pharmaceutical grade gelatin powder is a crucial component in the production of soft gel capsules, serving as the encapsulating agent. The rising prevalence of chronic diseases and the growing geriatric population have fuelled the demand for soft gel capsules as a preferred dosage form, thereby driving the demand for pharmaceutical grade gelatin powder.

"Expansion of Pharmaceutical Industry in Emerging Markets Helps the Market Growth"

Emerging economies are witnessing rapid growth in their pharmaceutical sectors, driven by factors such as increasing healthcare expenditure, improving healthcare infrastructure, and a growing focus on research and development. As pharmaceutical companies expand their operations in these markets to capitalize on the rising demand for medications, there is a corresponding increase in the demand for pharmaceutical grade gelatin powder. This growth is fuelled by its essential role in drug encapsulation, formulation, and stability, meeting the stringent quality standards required by the pharmaceutical industry.

RESTRAINING FACTOR

"Increase Production CostsImpediments to the Market Growth"

The pharmaceutical grade Gelatin powder market growth faces significant restraining factors, foremost among them being regulatory challenges and compliance requirements. Regulatory bodies impose stringent standards regarding the quality, safety, and sourcing of pharmaceutical ingredients, including Gelatin powder. Compliance with these regulations often necessitates extensive documentation, testing, and quality control measures, which can increase production costs and lead to delays in product approval and market entry. Moreover, changes in regulations or the introduction of new requirements can further complicate the manufacturing process and impact market dynamics, posing challenges for companies operating in this sector. These regulatory hurdles create barriers to entry and expansion in the pharmaceutical grade Gelatin powder market, constraining growth and innovation within the industry.

PHARMACEUTICAL GRADE GELATIN POWDER MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"North America to Dominate the Market Due to Region's Robust Infrastructure"

North America is poised to play a dominant role in the 600 MHz Nuclear Magnetic Resonance (NMR) Spectrometer Market. The region's prominence is attributed to a robust infrastructure for scientific research, a high concentration of leading academic and research institutions, and substantial investments in cutting-edge technologies. The United States, in particular, hosts numerous research facilities engaged in diverse fields such as chemistry, biochemistry, and pharmaceuticals, where NMR spectrometers find extensive applications. Additionally, the region's strong emphasis on innovation and collaboration between academia and industry further propels the demand for advanced analytical instruments like the 600 MHz NMR Spectrometer, solidifying North America's pivotal role in driving market growth.

KEY INDUSTRY PLAYERS

"Key Players Transforming the Gelatin Powder Market Landscape through Innovation and Global Strategy"

Gelco SA, GELITA, Rousselot, Tessenderlo Group PB Leiner, Nitta Gelatin Inc., and Jellice Gelatin & Collagen are key industry players in the gelatine market. Gelco SA, headquartered in Belgium, specializes in providing high-quality gelatin products for various applications. GELITA, based in Germany, is renowned for its innovative gelatin solutions catering to pharmaceutical, food, and technical industries. Rousselot, headquartered in France, is a global leader in collagen-based solutions, including gelatin, serving pharmaceutical, food, and nutrition sectors. Tessenderlo Group PB Leiner, also based in Belgium, is a major producer of gelatin and collagen peptides, offering a wide range of applications. Nitta Gelatin Inc., located in Japan, is a leading manufacturer of gelatin and collagen peptides with a strong presence in the global market. Jellice Gelatin & Collagen, while the specific headquarters location is not readily available, is recognized for its contributions to the gelatin and collagen industry, serving diverse sectors with its product offerings. These companies collectively play a significant role in shaping the gelatin market landscape through their expertise, innovation, and commitment to quality.

List of Market Players Profiled:

• Gelco SA (Belgium)
• GELITA (Germany)
• Rousselot (France)
• Tessenderlo Group PB Leiner (Belgium)
• Nitta Gelatin Inc. (Japan)

INDUSTRIAL DEVELOPMENT

May, 2020: A National Institute of Health (NIH) study revealed the use of bovine hydroxyapatite-gelatin-hydroxypropyl methylcellulose with alendronate as an injectable bone substitute (IBS) for osteoporosis treatment in animal models. The COVID-19 pandemic initially caused a gelatin shortage, affecting the global pharmaceutical gelatin industry. However, late in 2020, the market saw expansion due to relaxed regulations and heightened demand for gelatin in pharmaceuticals. This surge in demand, coupled with regulatory easing, mitigated the impacts of the shortage. Consequently, the global pharmaceutical gelatin industry experienced growth, indicating resilience and adaptability amidst challenging circumstances.

REPORT COVERAGE

The pharmaceutical grade gelatin powder market continues to evolve, driven by increasing demand for drug encapsulation and formulation across various therapeutic areas. Despite facing challenges such as regulatory hurdles and supply chain disruptions, the market is buoyed by factors like the expansion of the pharmaceutical industry in emerging markets and the growing preference for soft gel capsules. Moreover, the Asia Pacific region is expected to emerge as a dominant player, supported by its robust manufacturing capabilities and thriving pharmaceutical sector. As research and development efforts continue to innovate gelatin-based formulations and address regulatory requirements, the market is poised for sustained growth and development in the foreseeable future.